The mitochondria as a potential therapeutic target in cerebral I/R injury

Ischemic stroke is a major cause of mortality and disability worldwide. Among patients with ischemic stroke, the primary treatment goal is to reduce acute cerebral ischemic injury and limit the infarct size in a timely manner by ensuring effective cerebral reperfusion through the administration of e...

Full description

Saved in:
Bibliographic Details
Main Authors: Susu Fang, Wenzhou Huang, Xinhui Qu, Wen Chai
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2024.1500647/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556831261949952
author Susu Fang
Susu Fang
Wenzhou Huang
Wenzhou Huang
Xinhui Qu
Xinhui Qu
Wen Chai
author_facet Susu Fang
Susu Fang
Wenzhou Huang
Wenzhou Huang
Xinhui Qu
Xinhui Qu
Wen Chai
author_sort Susu Fang
collection DOAJ
description Ischemic stroke is a major cause of mortality and disability worldwide. Among patients with ischemic stroke, the primary treatment goal is to reduce acute cerebral ischemic injury and limit the infarct size in a timely manner by ensuring effective cerebral reperfusion through the administration of either intravenous thrombolysis or endovascular therapy. However, reperfusion can induce neuronal death, known as cerebral reperfusion injury, for which effective therapies are lacking. Accumulating data supports a paradigm whereby cerebral ischemia/reperfusion (I/R) injury is coupled with impaired mitochondrial function, contributing to the pathogenesis of ischemic stroke. Herein, we review recent evidence demonstrating a heterogeneous mitochondrial response following cerebral I/R injury, placing a specific focus on mitochondrial protein modifications, reactive oxygen species, calcium (Ca2+), inflammation, and quality control under experimental conditions using animal models.
format Article
id doaj-art-ed7a1cc91b6241b19c71b93ace79381e
institution Kabale University
issn 1662-453X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj-art-ed7a1cc91b6241b19c71b93ace79381e2025-01-07T06:40:25ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2025-01-011810.3389/fnins.2024.15006471500647The mitochondria as a potential therapeutic target in cerebral I/R injurySusu Fang0Susu Fang1Wenzhou Huang2Wenzhou Huang3Xinhui Qu4Xinhui Qu5Wen Chai6The Second Department of Neurology, Jiangxi Provincial People’s Hospital and The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaInstitute of Geriatrics, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaDepartment of Orthopedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, ChinaJiangxi Provincial Key Laboratory of Spine and Spinal Cord Disease, Nanchang, Jiangxi, ChinaThe Second Department of Neurology, Jiangxi Provincial People’s Hospital and The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaInstitute of Geriatrics, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaDepartment of Neurology, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaIschemic stroke is a major cause of mortality and disability worldwide. Among patients with ischemic stroke, the primary treatment goal is to reduce acute cerebral ischemic injury and limit the infarct size in a timely manner by ensuring effective cerebral reperfusion through the administration of either intravenous thrombolysis or endovascular therapy. However, reperfusion can induce neuronal death, known as cerebral reperfusion injury, for which effective therapies are lacking. Accumulating data supports a paradigm whereby cerebral ischemia/reperfusion (I/R) injury is coupled with impaired mitochondrial function, contributing to the pathogenesis of ischemic stroke. Herein, we review recent evidence demonstrating a heterogeneous mitochondrial response following cerebral I/R injury, placing a specific focus on mitochondrial protein modifications, reactive oxygen species, calcium (Ca2+), inflammation, and quality control under experimental conditions using animal models.https://www.frontiersin.org/articles/10.3389/fnins.2024.1500647/fullcerebral ischemia/reperfusion injury (CIRI)mitochondrionacetylationCa2+ROSinflammation
spellingShingle Susu Fang
Susu Fang
Wenzhou Huang
Wenzhou Huang
Xinhui Qu
Xinhui Qu
Wen Chai
The mitochondria as a potential therapeutic target in cerebral I/R injury
Frontiers in Neuroscience
cerebral ischemia/reperfusion injury (CIRI)
mitochondrion
acetylation
Ca2+
ROS
inflammation
title The mitochondria as a potential therapeutic target in cerebral I/R injury
title_full The mitochondria as a potential therapeutic target in cerebral I/R injury
title_fullStr The mitochondria as a potential therapeutic target in cerebral I/R injury
title_full_unstemmed The mitochondria as a potential therapeutic target in cerebral I/R injury
title_short The mitochondria as a potential therapeutic target in cerebral I/R injury
title_sort mitochondria as a potential therapeutic target in cerebral i r injury
topic cerebral ischemia/reperfusion injury (CIRI)
mitochondrion
acetylation
Ca2+
ROS
inflammation
url https://www.frontiersin.org/articles/10.3389/fnins.2024.1500647/full
work_keys_str_mv AT susufang themitochondriaasapotentialtherapeutictargetincerebralirinjury
AT susufang themitochondriaasapotentialtherapeutictargetincerebralirinjury
AT wenzhouhuang themitochondriaasapotentialtherapeutictargetincerebralirinjury
AT wenzhouhuang themitochondriaasapotentialtherapeutictargetincerebralirinjury
AT xinhuiqu themitochondriaasapotentialtherapeutictargetincerebralirinjury
AT xinhuiqu themitochondriaasapotentialtherapeutictargetincerebralirinjury
AT wenchai themitochondriaasapotentialtherapeutictargetincerebralirinjury
AT susufang mitochondriaasapotentialtherapeutictargetincerebralirinjury
AT susufang mitochondriaasapotentialtherapeutictargetincerebralirinjury
AT wenzhouhuang mitochondriaasapotentialtherapeutictargetincerebralirinjury
AT wenzhouhuang mitochondriaasapotentialtherapeutictargetincerebralirinjury
AT xinhuiqu mitochondriaasapotentialtherapeutictargetincerebralirinjury
AT xinhuiqu mitochondriaasapotentialtherapeutictargetincerebralirinjury
AT wenchai mitochondriaasapotentialtherapeutictargetincerebralirinjury